butanedioic acid; (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide CAS No.158930-09-7 / Cat No.EBD139926
frovatriptansuccinate
1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3r)-, butanedioate (1:1)
1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, butanedioate (1:1)
sb-209509ax
vml 251
fovatriptan succinate
(3r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide butanedioate
Frovatriptan Succinate
Frovatriptan succinate
SB-209509ax
VML 251
1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1)
1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1)
Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1)
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide butanedioate (1:1)
(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
succinic acid
butanedioic acid
(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
SB-209509ax
VML 251
Properties
-
Boiling point:
515.2 °C at 760mmHg
-
Flashing point:
265.4 °C
-
Vapour pressure:
1.01E-10mmHg at 25°C
NMR Spectrum
1H NMR
13C NMR
